GlassScriptPhysician profile
Zachary Samuel Hoffmann
NPI 1225411762
$1,827.62
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $834 · 2020: $366 · 2021: $628.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $365.27 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $261.84 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $250.81 | 2019-2021 | |
| Pfizer INC. | $243.74 | 2019-2021 | |
| Otsuka America Pharmaceutical, INC. | $174.66 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $166.23 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $85.01 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $69.21 | 2019-2021 | |
| Alexion Pharmaceuticals, INC. | $52.56 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $45.47 | 2020 | |
| Boston Scientific Corporation | $28.20 | 2019-2021 | |
| Cmp Pharma, INC. | $24.04 | 2021 | |
| Gilead Sciences, INC. | $20.44 | 2021 | |
| Philips North America LLC | $14.21 | 2021 | |
| Celgene Corporation | $13.78 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $12.15 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zachary Hoffmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.